Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

Trial Parameters

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.

Eligibility Criteria

Inclusion Criteria: * Sepsis defined by Sepsis-3 definition * Initial systolic blood pressure \< 90mmHg or blood lactate level \>2mmol/L Exclusion Criteria: * advanced directive for "Do not resuscitation" * recent systemic administration of glucocorticoid (4 weeks) * recent systemic administration of chemotherapy (4 weeks) * recent systemic administration of immunosuppressant (4 weeks) * expected life less than 90 days * Transferred from other hospital * Sepsis diagnosed 24 hours after ED admission * Use of etomidate in ED * pregnant or on lactation * no informed consent

Related Trials